GeneTex, Inc.

GeneTex, Inc. is a multinational biotechnology company that specializes in the development, manufacture, and validation of research antibodies, recombinant proteins, and other biomedical reagents. The company serves academic, biotechnology, and pharmaceutical research laboratories worldwide, providing a catalog of nearly 50,000 products focused on areas such as cancer biology, neuroscience, immunology, and infectious disease. Founded in 1997, GeneTex has established a strong reputation for its rigorous antibody validation strategies, including the use of recombinant monoclonal antibody technology. The company maintains state-of-the-art production and development facilities in both the United States (Irvine, California) and Taiwan, ensuring high standards of quality control and consistency for its global research clientele.